Tracy Butler

Blood-based Biomarkers for Alzheimer ’ s Disease and Related Dementias Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer ’ s disease

K. Blennow, M. D. de Leon, H. Zetterberg, 2019 .

Impaired sleep is associated with tau deposition on 18F-flortaucipir PET and accelerated cognitive decline, accounting for medications that affect sleep

Liangdong Zhou, M. D. Leon, Gloria C. Chiang, 2024, Journal of the Neurological Sciences.

Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects

K. Blennow, Yi Li, Patrick Harvey, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Evidence of Pericyte Damage in a Cognitively Normal Cohort

K. Blennow, S. Pahlajani, A. Haghdel, 2024, Alzheimer disease and associated disorders.

[1-11C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjects

H. Rusinek, R. Carare, N. Karakatsanis, 2024, Fluids and barriers of the CNS.

Brain Fluid Clearance After Traumatic Brain Injury Measured Using Dynamic Positron Emission Tomography

H. Rusinek, Liangdong Zhou, N. Karakatsanis, 2024, Neurotrauma reports.